ASCO: Palbociclib Ups Survival in HR+ Metastatic Breast Cancer
Adding palbociclib to standard hormone therapy kept disease from progressing for nine months
ASCO: Greater Breast Tissue Removal Reduces Further Surgery
Removing extra tissue can halve the chances of requiring a second surgery in breast cancer
Physician Intervention Doesn’t Cut Maternal Vaccine Hesitancy
Second study shows high PBE schools colocated with schools with elevated PME rates
May 2015 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for May 2015. This roundup includes the latest...
May 2015 Briefing – Pain Management
Here are what the editors at HealthDay consider to be the most important developments in Pain Management for May 2015. This roundup includes the...
May 2015 Briefing – Geriatrics
Here are what the editors at HealthDay consider to be the most important developments in Geriatrics for May 2015. This roundup includes the latest...
May 2015 Briefing – Cosmetic Surgery
Here are what the editors at HealthDay consider to be the most important developments in Cosmetic Surgery for May 2015. This roundup includes the...
May 2015 Briefing – Anesthesiology
Here are what the editors at HealthDay consider to be the most important developments in Anesthesiology for May 2015. This roundup includes the latest...
May 2015 Briefing – Radiology
Here are what the editors at HealthDay consider to be the most important developments in Radiology for May 2015. This roundup includes the latest...
May 2015 Briefing – Pathology
Here are what the editors at HealthDay consider to be the most important developments in Pathology for May 2015. This roundup includes the latest...
